Scientists have disrupted the function of MYC, a cancer regulator thought to be “undruggable.” The researchers found that a credit card-like molecule they developed moves in and disrupts critical interactions between MYC and its binding partner. The study also shows the drug candidate can stop tumor growth in animal models.